(*) EU CE Mark Date: 2022. 02.18
(*) JP Approval Date: 2020. 03.
(*) USA Approval Date: 2021. 02.03
Company
Company JP
Generic Name: Tepotinib
MET: Mesenchymal to Epithelial Tran
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 8
Patent>UpDate: 2021. 08.17.
PR Web-Site (USA)
RTM